The engine maker’s share price jumped from below 70p to above 120p earlier this week on coronavirus vaccine news
’s () new shares began trading on Thursday after its £2bn rights issue was completed.
Just over 94% of its fully underwritten 10-for-3 rights issue was taken up after it closed for acceptances a day earlier at a price of 32p per new share.
With the company receiving valid acceptances in respect of 6.06bn shares, its large band of brokers BNP Paribas, Citigroup, , , Jefferies, , Crédit Agricole CIB, Santander, SMBC Nikko and Société Générale found buyers for the remaining 375,096,792 shares at a price of 90p apiece.
The engine maker’s share price earlier this week jumped from below 70p to above 120p after positive news emerged about the coronavirus vaccine which will provide a boost to the travel sector and feed through to the company by supporting aeroplane sales and after-sales.
On Thursday afternoon, the FTSE 100 firm’s shares were down 8% to 90.52p.
Read More: Rolls-Royce Holdings PLC concludes rights issue with help of rump placing